Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6411 USD | -1.52% | -14.52% | +88.45% |
May. 09 | Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.45% | 11.36M | |
+29.31% | 49.18B | |
+0.92% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.27% | 26.09B | |
-22.71% | 18.71B | |
+8.11% | 13.26B | |
+32.14% | 12.32B | |
-0.68% | 11.99B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Monopar Therapeutics Reports Positive Clinical Data From Camsirubicin Therapy Trial